Alnylam Pharmaceuticals Inc (ALNY)
146.06
+0.27
(+0.19%)
USD |
NASDAQ |
Apr 23, 16:00
146.05
-0.01
(-0.01%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.439B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.439B |
| September 30, 2023 | 2.406B |
| June 30, 2023 | 2.058B |
| March 31, 2023 | 2.071B |
| December 31, 2022 | 2.192B |
| September 30, 2022 | 2.265B |
| June 30, 2022 | 2.111B |
| March 31, 2022 | 2.240B |
| December 31, 2021 | 2.436B |
| September 30, 2021 | 2.328B |
| June 30, 2021 | 1.900B |
| March 31, 2021 | 1.710B |
| December 31, 2020 | 1.874B |
| September 30, 2020 | 1.834B |
| June 30, 2020 | 1.926B |
| March 31, 2020 | 1.342B |
| December 31, 2019 | 1.536B |
| September 30, 2019 | 1.721B |
| June 30, 2019 | 1.927B |
| March 31, 2019 | 1.245B |
| December 31, 2018 | 1.084B |
| September 30, 2018 | 1.237B |
| June 30, 2018 | 1.448B |
| March 31, 2018 | 1.568B |
| December 31, 2017 | 1.691B |
| Date | Value |
|---|---|
| September 30, 2017 | 948.29M |
| June 30, 2017 | 923.27M |
| March 31, 2017 | 559.60M |
| December 31, 2016 | 626.80M |
| September 30, 2016 | 713.14M |
| June 30, 2016 | 856.40M |
| March 31, 2016 | 1.014B |
| December 31, 2015 | 1.081B |
| September 30, 2015 | 1.016B |
| June 30, 2015 | 1.005B |
| March 31, 2015 | 1.067B |
| December 31, 2014 | 696.69M |
| September 30, 2014 | 631.93M |
| June 30, 2014 | 654.76M |
| March 31, 2014 | 665.49M |
| December 31, 2013 | 245.87M |
| September 30, 2013 | 193.78M |
| June 30, 2013 | 209.69M |
| March 31, 2013 | 236.01M |
| December 31, 2012 | 122.81M |
| September 30, 2012 | 228.34M |
| June 30, 2012 | 229.02M |
| March 31, 2012 | 199.10M |
| December 31, 2011 | 146.40M |
| September 30, 2011 | 173.02M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.342B
Minimum
Mar 2020
2.439B
Maximum
Dec 2023
2.017B
Average
2.058B
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.331B |
| Pfizer Inc | 12.69B |
| Blueprint Medicines Corp | 710.64M |
| Madrigal Pharmaceuticals Inc | 634.13M |
| Sarepta Therapeutics Inc | 1.676B |